Tribun Health develops digital pathology and AI tools for diagnostics, research, and clinical trials.
Founded in 2016 and based in Paris, France, Tribun Health provides software and services for healthcare and drug development. Its CaloPix platform supports digital pathology, while its AI tools serve diagnostics, pharmaceutical and translational research, and clinical trials. In September 2023, the company raised EUR 15 million in Series B funding led by Bpifrance, with LBO France, Owkin, Inc., Vivalto Santé SAS, and other investors participating. It planned to develop and commercialize its products and expand in North America and Europe.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in